ODEFSEY

emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide · Gilead Sciences, Inc.

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for ODEFSEY, covering 2016-03-01 to 2025-02-19. Get the full timeline:

Most recent: FDA Approved: ODEFSEY — Supplemental Application (Gilead Sciences, Inc.)